A citation-based method for searching scientific literature

Kyoung-Mu Lee, Dalsu Baris, Yawei Zhang, H Dean Hosgood, Idan Menashe, Meredith Yeager, Shelia Hoar Zahm, Sophia S Wang, Mark P Purdue, Stephen Chanock, Tongzhang Zheng, Nathaniel Rothman, Qing Lan. Am J Hematol 2010
Times Cited: 15







List of co-cited articles
104 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Variation in innate immunity genes and risk of multiple myeloma.
Mark P Purdue, Qing Lan, Idan Menashe, Tongzhang Zheng, Yawei Zhang, Meredith Yeager, H Dean Hosgood, Shelia H Zahm, Stephen J Chanock, Nathaniel Rothman,[...]. Hematol Oncol 2011
17
26

Protective role of CYP1A1*2A in the development of multiple myeloma.
Seong-Ho Kang, Tae Young Kim, Ho Young Kim, Jong-Hyun Yoon, Han-Ik Cho, Sung Soo Yoon, Dae Hee Kang, Cheol Won Suh, Jae Hoon Lee, Dong Soon Lee. Acta Haematol 2008
18
26

Genetic variation in cell cycle and apoptosis related genes and multiple myeloma risk.
H Dean Hosgood, Dalsu Baris, Yawei Zhang, Sonja I Berndt, Idan Menashe, Lindsay M Morton, Kyoung-Mu Lee, Meredith Yeager, Shelia H Zahm, Stephen Chanock,[...]. Leuk Res 2009
14
28

LAG-3, a novel lymphocyte activation gene closely related to CD4.
F Triebel, S Jitsukawa, E Baixeras, S Roman-Roman, C Genevee, E Viegas-Pequignot, T Hercend. J Exp Med 1990
477
26

LAG-3 regulates plasmacytoid dendritic cell homeostasis.
Creg J Workman, Yao Wang, Karim C El Kasmi, Drew M Pardoll, Peter J Murray, Charles G Drake, Dario A A Vignali. J Immunol 2009
144
26

Haplotypes in the tumour necrosis factor region and myeloma.
Gareth J Morgan, Peter J Adamson, Fiona K Mensah, Charlotte F Spink, Graham R Law, Leigh J Keen, Eve Roman, Faith E Davies, Sara Rollinson, J A Child,[...]. Br J Haematol 2005
37
20

GSTM1 and codon 72 P53 polymorphism in multiple myeloma.
Manoela M Ortega, Helen N Honma, Lair Zambon, Irene Lorand-Metze, Fernando F Costa, Carmino A De Souza, Carmen S P Lima. Ann Hematol 2007
10
30

Association of interleukin-1A, interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms with multiple myeloma.
Danai Abazis-Stamboulieh, Pagona Oikonomou, Nikolaos Papadoulis, Panayiotis Panayiotidis, Efimia Vrakidou, Aspasia Tsezou. Leuk Lymphoma 2007
25
20

Polymorphisms in the genes ERCC2, XRCC3 and CD3EAP influence treatment outcome in multiple myeloma patients undergoing autologous bone marrow transplantation.
Annette Vangsted, Peter Gimsing, Tobias W Klausen, Bjørn A Nexø, Håkan Wallin, Pernille Andersen, Peter Hokland, Søren T Lillevang, Ulla Vogel. Int J Cancer 2007
42
20

Variation in DNA repair genes XRCC3, XRCC4, XRCC5 and susceptibility to myeloma.
Patrick J Hayden, Prerna Tewari, Derek W Morris, Anthony Staines, Dominique Crowley, Alexandra Nieters, Nikolaus Becker, Silvia de Sanjosé, Lenka Foretova, Marc Maynadié,[...]. Hum Mol Genet 2007
48
20

Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myeloma.
Brenda M Birmann, Rulla M Tamimi, Edward Giovannucci, Bernard Rosner, David J Hunter, Peter Kraft, Constantine Mitsiades, Kenneth C Anderson, Graham A Colditz. Cancer Epidemiol Biomarkers Prev 2009
31
20

Polymorphisms of methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), methionine synthase reductase (MTRR), and thymidylate synthase (TYMS) in multiple myeloma risk.
Carmen S P Lima, Manoela M Ortega, Margareth C Ozelo, Renato C Araujo, Cármino A De Souza, Irene Lorand-Metze, Joyce M Annichino-Bizzacchi, Fernando F Costa. Leuk Res 2008
31
20

Xenobiotic gene polymorphisms and susceptibility to multiple myeloma.
Lisa F Lincz, Ian Kerridge, Fiona E Scorgie, Michael Bailey, Arno Enno, Andrew Spencer. Haematologica 2004
32
20

Interleukin-6-related genotypes, body mass index, and risk of multiple myeloma and plasmacytoma.
Wendy Cozen, Mulugeta Gebregziabher, David V Conti, David J Van Den Berg, Gerhard A Coetzee, Sophia S Wang, Nathaniel Rothman, Leslie Bernstein, Patricia Hartge, Ann Morhbacher,[...]. Cancer Epidemiol Biomarkers Prev 2006
47
20

Multiple myeloma.
Marc S Raab, Klaus Podar, Iris Breitkreutz, Paul G Richardson, Kenneth C Anderson. Lancet 2009
554
20

Association of heparanase gene (HPSE) single nucleotide polymorphisms with hematological malignancies.
O Ostrovsky, M Korostishevsky, I Levite, M Leiba, H Galski, I Vlodavsky, A Nagler. Leukemia 2007
35
20

The polymorphism IL-1beta T-31C is associated with a longer overall survival in patients with multiple myeloma undergoing auto-SCT.
A J Vangsted, T W Klausen, W Ruminski, P Gimsing, N F Andersen, A O Gang, N Abildgaard, L M Knudsen, J L Nielsen, H Gregersen,[...]. Bone Marrow Transplant 2009
24
20

Familiality of benign and malignant paraproteinemias. A population-based cancer-registry study of multiple myeloma families.
Helga M Ogmundsdóttir, Vilhelmína Haraldsdóttirm, Gudmundur M Jóhannesson, Gudrídur Olafsdóttir, Kristín Bjarnadóttir, Helgi Sigvaldason, Hrafn Tulinius. Haematologica 2005
33
20


Analysis of MTHFR polymorphisms and P16 methylation and their correlation with clinical-biological features of multiple myeloma.
Patrizia Chiusolo, Giuliana Farina, Rossana Putzulu, Giovanni Reddiconto, Alessia Fiorini, Valerio De Stefano, Elena Rossi, Mariangela Palladino, Giuseppe Leone, Simona Sica. Ann Hematol 2006
16
20


Prevalence of monoclonal gammopathy of undetermined significance.
Robert A Kyle, Terry M Therneau, S Vincent Rajkumar, Dirk R Larson, Matthew F Plevak, Janice R Offord, Angela Dispenzieri, Jerry A Katzmann, L Joseph Melton. N Engl J Med 2006
807
20

Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden.
Sigurdur Y Kristinsson, Magnus Björkholm, Lynn R Goldin, Cecilie Blimark, Ulf-Henrik Mellqvist, Anders Wahlin, Ingemar Turesson, Ola Landgren. Int J Cancer 2009
54
20

Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden.
Ola Landgren, Sigurdur Y Kristinsson, Lynn R Goldin, Neil E Caporaso, Cecilie Blimark, Ulf-Henrik Mellqvist, Anders Wahlin, Magnus Bjorkholm, Ingemar Turesson. Blood 2009
108
20


Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study.
Ola Landgren, Martha S Linet, Mary L McMaster, Gloria Gridley, Kari Hemminki, Lynn R Goldin. Int J Cancer 2006
103
20

Lymphocyte-activation gene-3, an important immune checkpoint in cancer.
Yayi He, Christopher J Rivard, Leslie Rozeboom, Hui Yu, Kim Ellison, Ashley Kowalewski, Caicun Zhou, Fred R Hirsch. Cancer Sci 2016
111
20

Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients.
Maher K Gandhi, Eleanore Lambley, Jaikumar Duraiswamy, Ujjwal Dua, Corey Smith, Suzanne Elliott, Devinder Gill, Paula Marlton, John Seymour, Rajiv Khanna. Blood 2006
170
20

MHC class II engagement by its ligand LAG-3 (CD223) contributes to melanoma resistance to apoptosis.
Patrice Hemon, Francette Jean-Louis, Kiran Ramgolam, Chrystelle Brignone, Manuelle Viguier, Hervé Bachelez, Frédéric Triebel, Dominique Charron, Fawzi Aoudjit, Reem Al-Daccak,[...]. J Immunol 2011
125
20

Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer.
Junko Matsuzaki, Sacha Gnjatic, Paulette Mhawech-Fauceglia, Amy Beck, Austin Miller, Takemasa Tsuji, Cheryl Eppolito, Feng Qian, Shashikant Lele, Protul Shrikant,[...]. Proc Natl Acad Sci U S A 2010
570
20



High expression of lymphocyte-activation gene 3 (LAG3) in chronic lymphocytic leukemia cells is associated with unmutated immunoglobulin variable heavy chain region (IGHV) gene and reduced treatment-free survival.
Jana Kotaskova, Boris Tichy, Martin Trbusek, Hana Skuhrova Francova, Jitka Kabathova, Jitka Malcikova, Michael Doubek, Yvona Brychtova, Jiri Mayer, Sarka Pospisilova. J Mol Diagn 2010
29
20


Expression of lymphocyte activation gene 3 (LAG-3) on B cells is induced by T cells.
Malgorzata Kisielow, Jan Kisielow, Giuseppina Capoferri-Sollami, Klaus Karjalainen. Eur J Immunol 2005
147
20

Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk.
Dalemari Crowther-Swanepoel, Peter Broderick, Maria Chiara Di Bernardo, Sara E Dobbins, María Torres, Mahmoud Mansouri, Clara Ruiz-Ponte, Anna Enjuanes, Richard Rosenquist, Angel Carracedo,[...]. Nat Genet 2010
174
13

Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.
Lucia Conde, Eran Halperin, Nicholas K Akers, Kevin M Brown, Karin E Smedby, Nathaniel Rothman, Alexandra Nieters, Susan L Slager, Angela Brooks-Wilson, Luz Agana,[...]. Nat Genet 2010
120
13

Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma.
T Hideshima, N Nakamura, D Chauhan, K C Anderson. Oncogene 2001
382
13

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome.
Hervé Avet-Loiseau, Michel Attal, Philippe Moreau, Catherine Charbonnel, Frédéric Garban, Cyrille Hulin, Serge Leyvraz, Mauricette Michallet, Ibrahim Yakoub-Agha, Laurent Garderet,[...]. Blood 2007
651
13

Methionine synthase genetic polymorphism MS A2756G alters susceptibility to follicular but not diffuse large B-cell non-Hodgkin's lymphoma or multiple myeloma.
Lisa F Lincz, Fiona E Scorgie, Ian Kerridge, Rachelle Potts, Andrew Spencer, Arno Enno. Br J Haematol 2003
56
13

Comparative analysis of IL6 promoter and receptor polymorphisms in myelodysplasia and multiple myeloma.
I Aladzsity, M Kovács, A Semsei, A Falus, A Szilágyi, I Karádi, G Varga, G Füst, J Várkonyi. Leuk Res 2009
18
13

Associations of common variants in genes involved in metabolism and response to exogenous chemicals with risk of multiple myeloma.
Laura S Gold, Anneclaire J De Roos, Elizabeth E Brown, Qing Lan, Kevin Milliken, Scott Davis, Stephen J Chanock, Yawei Zhang, Richard Severson, Sheila H Zahm,[...]. Cancer Epidemiol 2009
18
13

Interleukin 6, tumour necrosis factor alpha, interleukin 1beta and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma.
C Zheng, D R Huang, S Bergenbrant, A Sundblad, A Osterborg, M Björkholm, G Holm, Q Yi. Br J Haematol 2000
72
13

The role of MTHFR gene in multiple myeloma.
Elias Zintzaras, Stavroula Giannouli, Paraskevi Rodopoulou, Michael Voulgarelis. J Hum Genet 2008
19
13

Polymorphisms and haplotypes in the multidrug resistance 1 gene (MDR1/ABCB1) and risk of multiple myeloma.
Krzysztof Jamroziak, Ewa Balcerczak, Karolina Calka, Sylwester Piaskowski, Halina Urbanska-Rys, Aleksandra Salagacka, Marek Mirowski, Tadeusz Robak. Leuk Res 2009
31
13

Common variants in genes that mediate immunity and risk of multiple myeloma.
Elizabeth E Brown, Qing Lan, Tongzhang Zheng, Yawei Zhang, Sophia S Wang, Shelia Hoar-Zahm, Stephen J Chanock, Nathaniel Rothman, Dalsu Baris. Int J Cancer 2007
26
13

Haplotypic structure across the I kappa B alpha gene (NFKBIA) and association with multiple myeloma.
Charlotte F Spink, Lisa C Gray, Faith E Davies, Gareth J Morgan, Jeffrey L Bidwell. Cancer Lett 2007
29
13

Immunodeficiency and immunotherapy in multiple myeloma.
Guy Pratt, Oliver Goodyear, Paul Moss. Br J Haematol 2007
238
13

Polymorphisms involved in the folate metabolizing pathway and risk of multiple myeloma.
Hee Nam Kim, Yeo-Kyeoung Kim, Il-Kwon Lee, Je-Jung Lee, Deok-Hwan Yang, Kyeong-Soo Park, Jin-Su Choi, Moo Rim Park, Deog Yeon Jo, Hyeoung-Joon Kim. Am J Hematol 2007
21
13

Multiple myeloma: a review of the epidemiologic literature.
Dominik D Alexander, Pamela J Mink, Hans-Olov Adami, Philip Cole, Jack S Mandel, Martin M Oken, Dimitrios Trichopoulos. Int J Cancer 2007
184
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.